New Alliance Capital
Private equityShanghai · Seed–Late Stage · 25 people tracked
Investment thesis
New Alliance Capital invests across information technology, healthcare, and future/frontier technology, backing companies at early, growth, and mature stages. Rooted in hard-tech industries, the firm emphasizes value-added services, drawing on its team's experience in state-enterprise restructuring, private venture investing, and multinational localization. It leverages industry and research resources to provide financial and strategic support to Chinese companies and entrepreneurs, aiming to nurture industry leaders with international competitiveness. The firm has completed over 150 investments, with more than 30 portfolio companies listed publicly, and manages multiple funds with cumulative assets exceeding RMB 17 billion.
Source: firm website, verified Aug 3, 2026.
Team · 25 people
from the firm's website & public directories
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Deep Tech ×1
Investments · 1 tracked
founders shown can be your intro pathArnatar develops RNA therapeutics using its DARGER platform, which combines gene silencing via siRNA with protein upregulation through antisense oligonucleotides (ACT-UP1).
BiotechDeep Tech
Co-investors3E Bioventures CapitalF-Prime CapitalApricot CapitalEight Roads VenturesGaorong VenturesLegend Star
Portfolio news
latest coverage across their companiesArnatar Therapeutics · dakota.com · Aug 18, 2026
Frequently asked questions
- What stage does New Alliance Capital invest at?
- New Alliance Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does New Alliance Capital focus on?
- New Alliance Capital focuses on AI & Machine Learning, Biotech, Consumer, Data & Infrastructure, Deep Tech, Digital Health, Energy, Enterprise Software, Fintech, Healthtech, Media & Entertainment, Medical Devices, New Materials, Retail Tech, SaaS.
- Where is New Alliance Capital located?
- New Alliance Capital is headquartered in Shanghai, CN.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
Venture Science is an investment firm applying research, mathematics, and decision theory to venture capital and public markets, powered by its proprietary in-house AI platform called Helix and its evergreen flagship fund Strata.